T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Exxon Mobil
XOM
|
+$1.68B |
| 2 |
Eli Lilly
LLY
|
+$1.43B |
| 3 |
Bank of America
BAC
|
+$1.17B |
| 4 |
Tesla
TSLA
|
+$1.13B |
| 5 |
Wells Fargo
WFC
|
+$734M |
Top Sells
| 1 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$20.6B |
| 2 |
Microsoft
MSFT
|
+$5.74B |
| 3 |
Amazon
AMZN
|
+$3.33B |
| 4 |
Yum! Brands
YUM
|
+$2.6B |
| 5 |
Salesforce
CRM
|
+$2.35B |
Sector Composition
| 1 | Technology | 26.11% |
| 2 | Healthcare | 18.73% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.33% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTRA
2051
DELISTED
Proterra Inc. Common Stock
PTRA
| $567K | ﹤0.01% |
113,681
+30,386
| +36% | +$152K |
|
2052
Enerpac Tool Group
EPAC
$2.3B
| $565K | ﹤0.01% |
31,653
-6,252,199
| -99% | -$112M |
|
2053
iShares Core Dividend Growth ETF
DGRO
$34.3B
| $563K | ﹤0.01% |
12,639
-800
| -6% | -$35.6K |
|
2054
Progress Software
PRGS
$1.82B
| $562K | ﹤0.01% |
13,186
+2,814
| +27% | +$120K |
|
2055
Ambac
AMBC
$413M
| $560K | ﹤0.01% |
43,895
+835
| +2% | +$10.7K |
|
2056
The Beauty Health Co
SKIN
$322M
| $560K | ﹤0.01% |
47,435
+11,317
| +31% | +$134K |
|
2057
PetMed Express
PETS
$58.5M
| $558K | ﹤0.01% |
28,543
+1,163
| +4% | +$22.7K |
|
2058
Lindsay Corp
LNN
$1.52B
| $556K | ﹤0.01% |
3,876
+1,727
| +80% | +$248K |
|
|
EVOP
2059
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $554K | ﹤0.01% |
16,619
+3,090
| +23% | +$103K |
|
2060
Horizon Bancorp
HBNC
$835M
| $552K | ﹤0.01% |
+30,671
| New | +$552K |
|
2061
MBIA
MBI
$388M
| $550K | ﹤0.01% |
59,741
+9,495
| +19% | +$87.4K |
|
2062
Archrock
AROC
$4.33B
| $549K | ﹤0.01% |
85,388
-42,526
| -33% | -$273K |
|
|
ALX
2063
Alexander's
ALX
$1.26B
| $547K | ﹤0.01% |
2,613
+828
| +46% | +$173K |
|
|
CLDT
2064
Chatham Lodging
CLDT
$350M
| $547K | ﹤0.01% |
55,338
-28,233
| -34% | -$279K |
|
|
DCT
2065
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $545K | ﹤0.01% |
45,947
-5,444,651
| -99% | -$64.6M |
|
2066
Cerence
CRNC
$444M
| $543K | ﹤0.01% |
34,470
+2,323
| +7% | +$36.6K |
|
|
VIA
2067
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $541K | ﹤0.01% |
15,644
-533
| -3% | -$18.4K |
|
|
CYBE
2068
DELISTED
Cyberoptics Corp
CYBE
| $541K | ﹤0.01% |
10,041
-2,544
| -20% | -$137K |
|
2069
Forrester Research
FORR
$196M
| $538K | ﹤0.01% |
14,938
-1,660
| -10% | -$59.8K |
|
2070
Vishay Precision Group
VPG
$418M
| $538K | ﹤0.01% |
18,160
+2,160
| +14% | +$64K |
|
2071
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $537K | ﹤0.01% |
55,776
+4,447
| +9% | +$42.8K |
|
2072
Banner Corp
BANR
$2.3B
| $535K | ﹤0.01% |
9,040
+2,193
| +32% | +$130K |
|
|
EQRXW
2073
DELISTED
EQRx, Inc. Warrant
EQRXW
| $535K | ﹤0.01% |
652,353
-4,240
| -0.6% | -$3.48K |
|
2074
Dillards
DDS
$9B
| $534K | ﹤0.01% |
1,956
-954
| -33% | -$260K |
|
2075
Douglas Elliman
DOUG
$239M
| $534K | ﹤0.01% |
136,502
+47,352
| +53% | +$185K |
|